Works matching IS 02780232 AND DT 2007 AND VI 25 AND IP 3

Results: 9

Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
Published in:
Hematological Oncology, 2007, v. 25, n. 3, p. 127, doi. 10.1002/hon.820
By:
- Kalpadakis, C;
- Pangalis, GA;
- Dimopoulou, MN;
- Vassilakopoulos, TP;
- Kyrtsonis, M-C;
- Korkolopoulou, P;
- Kontopidou, FN;
- Siakantaris, MP;
- Dimitriadou, EM;
- Kokoris, SI;
- Tsaftaridis, P;
- Plata, E;
- Angelopoulou, MK
Publication type:
Article
Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with Essential Thrombocythemia.
Published in:
Hematological Oncology, 2007, v. 25, n. 3, p. 115, doi. 10.1002/hon.816
By:
- Radaelli, Franca;
- Colombi, Mariangela;
- Calori, Rossella;
- Zilioli, Vittorio Ruggero;
- Bramanti, Stefania;
- Iurlo, Alessandra;
- Zanella, Alberto
Publication type:
Article
Phase II study of CLAD (cyclophosphamide, liposomal doxorubicin and dexamethasone) in patients with advanced multiple myeloma and historical comparison to CAD (cyclophosphamide, doxorubicin and dexamethasone)
Published in:
2007
By:
- Hütter G;
- Szélenyi H;
- Schmittel A;
- Siehl JM;
- Thiel E;
- Keilholz U
Publication type:
Journal Article
Prognostic relevance of circulating matrix metalloproteinase-2 in acute myeloid leukaemia patients.
Published in:
Hematological Oncology, 2007, v. 25, n. 3, p. 121, doi. 10.1002/hon.817
By:
- Aref, Salah;
- Osman, E.;
- Mansy, S.;
- Omer, N.;
- Azmy, E.;
- Goda, T.;
- El-Sherbiny, M.
Publication type:
Article
Current Awareness in Hematological Oncology.
Published in:
Hematological Oncology, 2007, v. 25, n. 3, p. 148, doi. 10.1002/hon.797
Publication type:
Article
First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts.
Published in:
Hematological Oncology, 2007, v. 25, n. 3, p. 143, doi. 10.1002/hon.822
By:
- Andrikovics, Hajnalka;
- Nahajevszky, Sarolta;
- Szilvási, Anikó;
- Bors, András;
- Ádám, Emma;
- Kozma, András;
- Kajtár, Béla;
- Barta, Anikó;
- Poros, Anna;
- Tordai, Attila
Publication type:
Article
A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma.
Published in:
Hematological Oncology, 2007, v. 25, n. 3, p. 107, doi. 10.1002/hon.815
By:
- Tsurumi, Hisashi;
- Hara, Takeshi;
- Goto, Naoe;
- Kanemura, Nobuhiro;
- Kasahara, Senji;
- Sawada, Michio;
- Yasuda, Ichiro;
- Yamada, Toshiki;
- Shimizu, Masahito;
- Takami, Tsuyoshi;
- Moriwaki, Hisataka
Publication type:
Article
Phase II study of CLAD (cyclophosphamide, liposomal doxorubicin and dexamethasone) in patients with advanced multiple myeloma and historical comparison to CAD (cyclophosphamide, doxorubicin and dexamethasone).
Published in:
Hematological Oncology, 2007, v. 25, n. 3, p. 132, doi. 10.1002/hon.821
By:
- Hütter, G.;
- Szélenyi, H.;
- Schmittel, A.;
- Siehl, J. M.;
- Thiel, E.;
- Keilholz, U.
Publication type:
Article
Senile EBV-associated B-cell lymphoproliferative disorder of prepatellar bursa in an elderly patient with multifocal urate arthropathy.
Published in:
Hematological Oncology, 2007, v. 25, n. 3, p. 140, doi. 10.1002/hon.814
By:
- Mueller, Susanna;
- Aigner, Thomas;
- Haag, Jochen;
- Schwarz, Rene;
- Niedobitek, Gerald
Publication type:
Article